GLP Watchdog

Fridays vs Layla

Neither Fridays nor Layla has an FDA warning letter on record. On brand-name tirzepatide pen, Layla costs $5,148 less a year at standing rates: $1,399 a month against $1,828 a month at Fridays. It is one of two products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Layla

Fridays logo

Fridays

5.8/10

Layla logo

Layla

6.8/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$237/moCompounded oral semaglutide
States
No state list published
No state list published
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit FridaysFull review
Visit LaylaFull review

Neither Fridays nor Layla pays us. Links to them earn nothing. Scores: Fridays 5.8, Layla 6.8. How we are paid

What the record shows

  1. 01

    Neither Fridays nor Layla has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Layla names no compounding pharmacy in our record.

  3. 03

    On brand-name tirzepatide pen, Layla costs $5,148 less a year at standing rates: $1,399 a month against $1,828 a month at Fridays. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only Layla lists a price for compounded oral semaglutide.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Layla

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

$1,399/moLower

$16,788 a year

Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

$1,399/moLower

$16,788 a year

Compounded semaglutide injection

$249/mo

$2,988 a year

Not sold or not priced
Compounded tirzepatide injection

$359/mo

$4,308 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$237/mo

$2,844 a year

Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None; 30 days' notice
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
If a sent prescription order can be canceled, a $100 visit and clinical fee is kept
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Fridays: September 28, 2026. Layla: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Layla does not price
  • Names its compounding pharmacy
Visit Fridays

The case for Layla

6.8/10
  • $1,188 a year less on brand-name semaglutide pen
  • $5,148 a year less on brand-name tirzepatide pen
  • Sells compounded oral semaglutide, which Fridays does not price
  • Names no compounding pharmacy
Visit Layla

Scores

Fridays 5.8 · Layla 6.8 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.7

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
6.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Layla: questions

Neither Fridays nor Layla has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Layla names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Layla, by $1,188 a year at standing rates. Fridays: $1,498 a month, about $17,976 a year. Layla: $1,399 a month, about $16,788 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Layla states you can cancel at any time; refunds: if a sent prescription order can be canceled, a $100 visit and clinical fee is kept.
Neither Fridays nor Layla pays us. Links to them earn nothing. Scores: Fridays 5.8, Layla 6.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks